Transcatheter aortic valve replacement outcomes in patients with low-flow very low-gradient aortic stenosis

Hiroki A Ueyama1,2,3, Lakshay Chopra1,2, Ankur Dalsania1

  • 1Division of Cardiology, Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, One Gustave L. Levy Place, New York, NY 10029, USA.

Insights

Patients with severe aortic stenosis and very low-flow low-gradient (LG) have worse outcomes. Transcatheter aortic valve replacement (TAVR) did not show benefit in this distinct population, indicating a need for further research.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Severe aortic stenosis (AS) with low-flow low-gradient (LG) is associated with poor prognosis.
  • Very low-flow LG (mean pressure gradient ≤ 20 mmHg) may indicate a unique patient subgroup with advanced cardiac dysfunction.

Purpose of the Study:

  • To characterize patients with very low-flow LG severe AS.
  • To evaluate the clinical outcomes and TAVR benefit in this specific AS population.

Main Methods:

  • Single-center retrospective study of 662 patients with low-flow severe AS (2019-2021).
  • Patients categorized into very LG (MPG ≤ 20 mmHg), LG (20 < MPG < 40 mmHg), and high-gradient (HG) (MPG ≥ 40 mmHg) groups.
  • Comparison of composite endpoint (all-cause mortality, heart failure rehospitalization) between groups and after TAVR versus conservative management.

Main Results:

  • The very LG cohort (20%) exhibited higher comorbidities and lower LVEF (45%) compared to LG (51%) and HG (29%) groups.
  • A graded increase in adverse events was observed with decreasing MPG.
  • In TAVR recipients, very LG was an independent predictor of adverse outcomes (aHR 2.42).
  • TAVR reduced adverse events in LG and HG groups but not in the very LG group (aHR 0.69).

Conclusions:

  • Very low-flow LG severe AS defines a distinct patient group with substantial comorbidities and poorer outcomes.
  • Transcatheter aortic valve replacement (TAVR) does not appear to confer a survival or rehospitalization benefit in this specific subgroup.
  • Further research is required to ascertain the optimal management strategy and TAVR efficacy in patients with very low-flow LG severe AS.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
12
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
24
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
30
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
14